• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超低剂量联合治疗与单药治疗初始治疗时血压降低的性别差异。QUARTET的二次分析。

Sex differences in blood pressure lowering of initial treatment with ultra-low dose combination therapy versus monotherapy. A secondary analysis of QUARTET.

作者信息

O'Hagan Edel T, Marschner Simone L, Quintans Desi, Hillis Graham S, Atkins Emily R, Zaman Sarah, Schlaich Markus P, Rodgers Anthony, Chow Clara K

机构信息

Westmead Applied Research Centre, Faculty of Medicine and Health, The University of Sydney, Australia.

Department of Cardiology, Royal Perth Hospital.

出版信息

J Hypertens. 2025 Jul 1;43(7):1256-1260. doi: 10.1097/HJH.0000000000004024. Epub 2025 Apr 24.

DOI:10.1097/HJH.0000000000004024
PMID:40178246
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12144527/
Abstract

Women with hypertension are more likely than men to have ineffective treatment where blood pressure (BP) is treated but not controlled. The aim of this study was to investigate whether a quadpill based strategy differs between males and females. A secondary analysis of The Quadruple UltrA-low-dose tReaTment for hypErTension (QUARTET); randomized controlled trial. In this analysis the primary outcome was sex differences in unattended office systolic BP at 12 weeks. The QUARTET study recruited 591 participants (40% female) with mean age 59 (standard deviation 12) years [male 57 (12); female 62 (11)]. Males and females recorded a similar reduction in unattended systolic BP at 12 weeks with no interaction between group allocation and sex [male:mean difference (MD) in mmHg -6.95 (95% CI -9.53 to -4.38), female: MD -6.34 (95% CI -9.50 to -3.18), interaction P  = 0.77]. The quadpill strategy was similarly effective in men and women. Initiating BP control with a quadpill in women presents a promising approach to achieving similar BP control levels to men.

摘要

高血压女性在接受血压治疗但未得到控制的情况下,比男性更有可能接受无效治疗。本研究的目的是调查基于四联片的治疗策略在男性和女性之间是否存在差异。对高血压四联超低剂量治疗(QUARTET)随机对照试验进行二次分析。在此分析中,主要结局是12周时未监测的诊室收缩压的性别差异。QUARTET研究招募了591名参与者(40%为女性),平均年龄59(标准差12)岁[男性57(12);女性62(11)]。男性和女性在12周时未监测的收缩压下降幅度相似,组分配与性别之间无相互作用[男性:平均差值(MD),以mmHg计为-6.95(95%置信区间-9.53至-4.38),女性:MD -6.34(95%置信区间-9.50至-3.18),相互作用P = 0.77]。四联片策略在男性和女性中同样有效。对女性采用四联片启动血压控制是实现与男性相似血压控制水平的一种有前景的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff59/12144527/880e53c3756c/jhype-43-1256-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff59/12144527/880e53c3756c/jhype-43-1256-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff59/12144527/880e53c3756c/jhype-43-1256-g001.jpg

相似文献

1
Sex differences in blood pressure lowering of initial treatment with ultra-low dose combination therapy versus monotherapy. A secondary analysis of QUARTET.超低剂量联合治疗与单药治疗初始治疗时血压降低的性别差异。QUARTET的二次分析。
J Hypertens. 2025 Jul 1;43(7):1256-1260. doi: 10.1097/HJH.0000000000004024. Epub 2025 Apr 24.
2
Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial.在高血压患者中,使用包含四分之一剂量的四种降压药物的单片复方制剂进行单药初始治疗与标准剂量单药治疗的疗效比较(QUARTET):一项 3 期、随机、双盲、阳性对照试验。
Lancet. 2021 Sep 18;398(10305):1043-1052. doi: 10.1016/S0140-6736(21)01922-X. Epub 2021 Aug 29.
3
Ambulatory blood pressure after 12 weeks of quadruple combination of quarter doses of blood pressure medication vs. standard medication.四分之一剂量降压药物四联治疗 12 周后的动态血压。
J Hypertens. 2024 Jun 1;42(6):1009-1018. doi: 10.1097/HJH.0000000000003683. Epub 2024 Feb 28.
4
Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review.四分之一剂量四联疗法治疗高血压的初始治疗:安慰剂对照、交叉、随机试验和系统评价。
Lancet. 2017 Mar 11;389(10073):1035-1042. doi: 10.1016/S0140-6736(17)30260-X. Epub 2017 Feb 10.
5
Ultra-low-dose quadruple combination blood pressure-lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol.高血压患者的超低剂量四联降压治疗:QUARTET 随机对照试验方案。
Am Heart J. 2021 Jan;231:56-67. doi: 10.1016/j.ahj.2020.09.017. Epub 2020 Oct 2.
6
Therapeutic Inertia With Initial Low-Dose Quadruple Combination Therapy for Hypertension: Results From the QUARTET Trial.初始低剂量四联疗法治疗高血压的治疗惰性:QUARTET 试验结果。
Hypertension. 2024 May;81(5):1087-1094. doi: 10.1161/HYPERTENSIONAHA.123.22284. Epub 2024 Mar 13.
7
Use of Quadruple Therapy in the Management of Hypertension: A Systematic Review of Randomized Controlled Trials.四联疗法在高血压管理中的应用:随机对照试验的系统评价
Medicina (Kaunas). 2025 Apr 21;61(4):764. doi: 10.3390/medicina61040764.
8
Efficacy and safety of a four-drug, quarter-dose treatment for hypertension: the QUARTET USA randomized trial.四药联合、半量治疗高血压的疗效和安全性:QUARTET USA 随机试验。
Hypertens Res. 2024 Jun;47(6):1668-1677. doi: 10.1038/s41440-024-01658-y. Epub 2024 Apr 8.
9
Participants' views of ultra-low dose combination therapy for high blood pressure: a mixed-methods study from the QUARTET trial.参与者对超低剂量联合治疗高血压的看法:QUARTET 试验的混合方法研究。
J Hum Hypertens. 2024 Jun;38(6):516-522. doi: 10.1038/s41371-024-00915-4. Epub 2024 May 14.
10
Efficacy and safety of a quadruple ultra-low-dose treatment for hypertension (QUARTET USA): Rationale and design for a randomized controlled trial.一种用于治疗高血压的四重超低剂量治疗方案(QUARTET USA)的疗效和安全性:一项随机对照试验的原理和设计。
Am Heart J. 2022 Dec;254:183-193. doi: 10.1016/j.ahj.2022.09.004. Epub 2022 Sep 15.

本文引用的文献

1
Participants' views of ultra-low dose combination therapy for high blood pressure: a mixed-methods study from the QUARTET trial.参与者对超低剂量联合治疗高血压的看法:QUARTET 试验的混合方法研究。
J Hum Hypertens. 2024 Jun;38(6):516-522. doi: 10.1038/s41371-024-00915-4. Epub 2024 May 14.
2
Therapeutic Inertia With Initial Low-Dose Quadruple Combination Therapy for Hypertension: Results From the QUARTET Trial.初始低剂量四联疗法治疗高血压的治疗惰性:QUARTET 试验结果。
Hypertension. 2024 May;81(5):1087-1094. doi: 10.1161/HYPERTENSIONAHA.123.22284. Epub 2024 Mar 13.
3
Hypertension therapy using fixed-dose polypills that contain at least three medications.
使用包含至少三种药物的固定剂量复方制剂进行高血压治疗。
Heart. 2023 Aug 11;109(17):1273-1280. doi: 10.1136/heartjnl-2022-321496.
4
Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial.在高血压患者中,使用包含四分之一剂量的四种降压药物的单片复方制剂进行单药初始治疗与标准剂量单药治疗的疗效比较(QUARTET):一项 3 期、随机、双盲、阳性对照试验。
Lancet. 2021 Sep 18;398(10305):1043-1052. doi: 10.1016/S0140-6736(21)01922-X. Epub 2021 Aug 29.
5
The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030.柳叶刀妇女与心血管疾病委员会:到 2030 年降低全球负担。
Lancet. 2021 Jun 19;397(10292):2385-2438. doi: 10.1016/S0140-6736(21)00684-X. Epub 2021 May 16.
6
A double-blind, placebo-controlled trial on the antihypertensive treatment effect of a quadruple single-pill combination.一项关于四重单一片剂联合治疗的抗高血压治疗效果的双盲、安慰剂对照试验。
J Clin Hypertens (Greenwich). 2021 Apr;23(4):815-822. doi: 10.1111/jch.14207. Epub 2021 Feb 6.
7
Low-Dose Triple Antihypertensive Combination Therapy in Patients with Hypertension: A Randomized, Double-Blind, Phase II Study.高血压患者的低剂量三联抗高血压联合治疗:一项随机、双盲、Ⅱ期研究。
Drug Des Devel Ther. 2020 Dec 31;14:5735-5746. doi: 10.2147/DDDT.S286586. eCollection 2020.
8
Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical Trial.固定低剂量三联抗高血压药物与常规护理治疗斯里兰卡轻中度高血压患者的血压控制:一项随机临床试验。
JAMA. 2018 Aug 14;320(6):566-579. doi: 10.1001/jama.2018.10359.
9
Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials.降压药物低剂量联合治疗的价值:354项随机试验分析
BMJ. 2003 Jun 28;326(7404):1427. doi: 10.1136/bmj.326.7404.1427.